BSEGeneral30 Sept 2026 · 30 Sept 2026, 02:54 pm
OUTCOME OF BOARD MEETING HELD ON 30-09-2026
Aarey Drugs & Pharmaceuticals Ltd · 524412
✦ AI SummaryFundraise
Aarey Drugs & Pharmaceuticals Ltd has approved the allotment of 11,50,000 Equity Shares of Rs. 10/- each pursuant to Conversion of Fully Convertible Equity Share Warrants upon receipt of Rs. 47.85/- per warrant.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aarey Drugs & Pharmaceuticals Ltd - 524412 - Board Meeting Outcome for OUTCOME OF BOARD MEETING HELD ON 30-09-2026
Attachments (1)
📄pdf
Download →
7ba270a2-88cd-43cc-a51f-3f0f9611e31d.pdf
View document text
30-09-2026
To, To,
National Stock Exchange of India Ltd., Listing Operation,
Exchange Plaza, C-1, Block G, BSE Limited,
Bandra Kurla Complex, 20th Floor, P.J.Towers,
Bandra (E), Mumbai – 400 051 Dalal Street, Mumbai – 400 001.
Sub: Outcome for the Board Meeting held on 30-09-2026 at 11.30 AM and Concluded at 12.30 PM
Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for
allotment of 11,50,000 Equity Shares pursuant to Conversion of Warrants.
Dear Sir/Madam,
This is with reference to allotment of 50,00,000 Convertible Warrants of Face Value Rs. 10/- Each on
Preferential allotment basis at an Offer Price of Rs. 63.80/- Each and pursuant to members’ approval
dated January 02, 2025 the Board of Directors of the Company at its meeting held i.e. 30-09-2026 at
11.30 AM and Concluded at 12.30 PM have approved the allotment of 11,50,000 Equity Shares of Rs.
10/- each pursuant to Conversion of Fully Convertible Equity Share Warrants ("Warrants") upon
receipt of Rs. 47.85/- per warrant (being 75% of the issue price i.e. Rs. 63.80/- Per Warrant}
aggregating to Rs. 5,50,27,500/- to the persons belonging to both promoter and non-promoter
Category.
Pursuant to the above allotment, the issued and paid-up capital of the Company shall be as under:
Particulars Before Allotment After Allotment in Board After Allotment in Board
Meeting 06-08-2026 Meeting 30-09-2026
No. of Value No. of Value No. of Value
Shares (FV Rs. 10/-) Shares (FV Rs. 10/-) Shares (FV Rs. 10/-)
Issued 28354303 Rs. 283543030/- 30724303 Rs.307243030 31874303 Rs. 318743030/-
Capital
Paid-up 28354303 Rs. 283543030/- 30724303 Rs. 307243030 31874303 Rs. 318743030/-
Capital
Pursuant to Regulation 30 and Schedule III of the Listing Regulations, read with the SEBI Circular No.
SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 (“SEBI Disclosure Circular”), the detailed
disclosure in respect of the allotment of equity shares pursuant to conversion of warrants is set out
below at Annexure-A.
Furthermore, read with the outcome of Board Meeting 06-08-2026 please find enclosed revised
Annexure I table.
Thanking You
Yours faithfully,
FOR AAREY DRUGS AND PHARMACEUTICLES LIMITED
NIMIT GHATALIA
DIRECTOR
DIN: 07069841
Encl.: As Above
ANNEXURE A
SR. PARTICULARS OF SECURITIES DETAILS
a. Type of Securities Issued Equity Shares issued upon exercise of the convertible warrants
b. Type of Issue Equity shares issued upon exercise of the Convertible Warrants
which were issued by way of a preferential allotment.
c. Issue Price Rs. 63.80/- per warrant (at Premium of Rs. 53.80/-) as
determined in accordance with Chapter V of the Securities and
Exchange Board of India (Issue of Capital and Disclosure
Requirements) Regulations, 2018 ("SEBI ICDR Regulations")
d. In case of preferential issue, the listed entity shall disclose the following additional details to the
stock exchange(s):-
1. Name of Investors and their As Per Annexure I & Annexure II
corresponding subscription of No.
of Warrants
2. In case of convertibles - Exercise of 50,00,000 fully convertible warrants into 50,00,000
intimation on conversion of fully paid-up Equity Shares of the Company of FV Rs. 10 /- Each.
securities or on lapse of the
Tenure for Conversion into Equity Shares is 18 months from the
tenure of the instrument;
date of allotment i.e. 23-05-2025.
1. 23,70,000 Convertible Warrants Converted into Equity
Shares in the Board Meeting held on 06-08-2026.
2. 11,50,000 Convertible Warrants Converted into Equity
Shares in the Board Meeting held on 30-09-2026
3. 14,80,000 Convertible Warrants Outstanding for Conversion
into Equity Shares within 18 Months from date of allotment
i.e. 23-05-2025.
Annexure I:
List of Allottees to whom Equity Shares are Allotted pursuant to Conversion of Warrants as on
06-08-2026:
Sr. No. Name Pre- Pre No. Of No. Of Post Post Category
holding holding warrants Warrants allotment holding %
% Allotted Converted holding
on 23-05- into Equity
2025
Promoter &
Bina Rajesh
1 4003584 14.12% 500000 500000 4503584 14.66% Promoter
Ghatalia
Group
Mihir Promoter &
2 Rajesh 2835888 10.00% 345000 345000 3180888 10.35% Promoter
Ghatalia Group
Nimit Promoter &
3 Rajesh 1150000 4.06% 500000 350000 1500000 4.88% Promoter
Ghatalia Group
Promoter &
Mira Mihir
4 690000 2.43% 250000 250000 940000 3.06% Promoter
Ghatalia
Group
Promoter &
Ekta Nimit
5 0 0.00% 500000 500000 500000 1.63% Promoter
Ghatalia
Group
Mihir
Promoter &
Rajesh
6 0 0.00% 245000 245000 245000 0.80% Promoter
Ghatalia
Group
(HUF)
Rajesh Promoter &
7 Pranlal 2,971 0.01% 180000 180000 182971 0.60% Promoter
Ghatalia Group
Enam
Promoter &
Organics
8 0 0.00% 345000 0 0 0.00% Promoter
India
Group
Limited
Sr. No. Name Pre- Pre No. Of No. Of Post Post Category
holding holding warrants Warrants allotment holding %
% Allotted Converted holding
on 23-05- into Equity
2025
Nimit Impex Promoter &
9 Private 2010000 7.09% 345000 0 0 0.00% Promoter
Limited Group
Suraj
Promoter &
Tradelinks
10 0 0.00% 345000 0 0 0.00% Promoter
Private
Group
Limited
Worth
Investment Promoter &
11 and Trading 0 0.00% 345000 0 0 0.00% Promoter
Company Group
Limited
Archana
12 Pramod 0 0.00% 200000 0 0 0.00% Public
Wani
Priti
13 Vijaykumar 0 0.00% 500000 0 0 0.00% Public
Shah
Vaishali
14 0 0.00% 250000 0 0 0.00% Public
Aggarwal
Mamta
15 Girish 500 0.00% 100000 0 0 0.00% Public
Chheda
Sujata
16 Tushar 0 0.00% 25000 0 0 0.00% Public
Mehta
Tushar
17 0 0.00% 25000 0 0 0.00% Public
Mehta Huf
Annexure I:
List of Allottees to whom Equity Shares are Allotted pursuant to Conversion of Warrants as on 30-
09-2026:
Sr. No. Name Pre- Pre No. Of Post Post Category
holding holding Warrants allotment holding %
% Converted holding
into Equity
30-09-
2026
1 Bina Rajesh Promoter &
4503584 14.66 0 4503584 14.13%
Ghatalia Promoter Group
2 Mihir Rajesh Promoter &
3180888 10.35 0 3180888 9.98%
Ghatalia Promoter Group
3 Nimit Rajesh Promoter &
1500000 4.88 150000 1650000 5.18%
Ghatalia Promoter Group
4 Mira Mihir Promoter &
940000 3.06 0 940000 2.95%
Ghatalia Promoter Group
5 Ekta Nimit Promoter &
500000 1.63 0 500000 1.57%
Ghatalia Promoter Group
6 Mihir Rajesh
Promoter &
Ghatalia (HUF) 245000 0.80 0 245000 0.77%
Promoter Group
7 Rajesh Pranlal Promoter &
182971 0.60 0 182971 0.57%
Ghatalia Promoter Group
8 Enam Organics
Promoter &
0 0.00 0 0 0.00%
India Limited
Promoter Group
9 Nimit Impex Promoter &
0 0.00 0 2010000 6.31%
Private Limited Promoter Group
10 Suraj Tradelinks
Private Limited Promoter &
0 0.00 0 0 0.00%
Promoter Group
11 Worth
Investment and Promoter &
0 0.00 0 0 0.00%
Trading Company Promoter Group
Limited
Sr. No. Name Pre- Pre No. Of Post Post Category
holding holding Warrants allotment holding %
% Converted holding
into Equity
30-09-
2026
12 Archana Pramod
0 0.00 200000 200000 0.63% Public
Wani
13 Priti Vijaykumar
0 0.00 500000 500000 1.57% Public
Shah
14 Vaishali Aggarwal 0 0.00 250000 250000 0.78% Public
15 Mamta Girish
0 0.00 0 0 0.00% Public
Chheda
16 Sujata Tushar
0 0.00 25000 25000 0.08% Public
Mehta
17 Tushar Mehta
0 0.00 25000 25000 0.08% Public
FOR AAREY DRUGS AND PHARMACEUTICLES LIMITED
NIMIT GHATALIA
DIRECTOR
DIN: 07069841